Fidelity Contrafund

investment firm

About

Fidelity Contrafund is an online platform offering mutual fund research tools.

Details

Founded date
Jan 1, 2003
Operating Status
Active
Investor Type
Venture Capital

Fidelity Contrafund - Fidelity Advisor New Insights Fund is an open ended equity mutual fund launched by Fidelity Investments. It is co-managed by Fidelity Management & Research Company, FMR Co., Inc., Fidelity Research & Analysis Company, Fidelity Management & Research (U.K.) Inc., Fidelity International Investment Advisors (U.K.) Limited, Fidelity Investments Japan Limited, and Fidelity International Investment Advisors. The fund primarily invests in the public equity markets across the globe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the growth or value stocks of companies. It employs fundamental analysis with a bottom-up approach with a focus on factors such as financial condition, earnings outlook, strategy, management, industry position, and economic and market conditions to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index. Fidelity Contrafund - Fidelity Advisor New Insights Fund was formed on August 12, 2003 and is domiciled in the United States.

Investments

Number of Investments
Number of Lead Investments
2
0
Fidelity Contrafund has made 2 investments. Their most recent investment was on May 22, 2018, when Heal raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
May 22, 2018 Heal
Series C $20M Apps
Nov 19, 2009 Standard BioTools
Series Unknown $7.50M Biotechnology

Exits

Fidelity Contrafund has had 1 exits. Fidelity Contrafund most notable exits include Standard BioTools

Date Company Name Exit Type Industry
Feb 10, 2011 Standard BioTools IPO Biotechnology Detail